Tag: Metastatic
AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer...
Developed in collaboration with Daiichi Sankyo, Trastuzumab deruxtecan is a specifically engineered HER2-directed antibody drug conjugate
AstraZeneca’s Durvalumab receives CDSCO approval in India
The product is used for treatment of patients with locally advanced or metastatic Biliary Tract Cancer
Curadev Pharma gets FDA nod for phase-1 study of its cancer...
The company has received US-FDA's 'Study May Proceed' letter for its Investigational New Drug Application of CRD3874, an IV-Administered STING Agonist for the treatment of advanced/metastatic solid cancers
Panacea Biotec gets USFDA’s nod for its generic breast cancer drug
The company is looking ahead at commercializing the what it calls the best product in the United States and several other markets worldwide in collaboration with Apotex.............